Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology

Osteoarthritis and Cartilage

Volumn 9, Issue 3, 2001, Pages 203-214

  Volck, B ^a,b   Johansen, J S ^a   Stoltenberg, M ^a   Price, P A ^d   Otergaard M ^a   Ostergaard, K ^c   LOvgreen Nielsen P ^a   Sonne Holm, S ^a   Lorenzen, I ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Human cartilage glycoprotein 39; Osteoarthritis; Rheumatoid arthritis; YKL 40

Indexed keywords

GLUCOCORTICOID; GLYCOPROTEIN GP 39;

ADULT; AGED; ARTICLE; CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JOINT EFFUSION; KNEE OSTEOARTHRITIS; LEUKOCYTE ACTIVATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; RELAPSE; REMISSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVITIS; SYNOVIUM;

EID: 0035028329     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.2000.0377     Document Type: Article

References (44)

1. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family
2. Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period
3. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid
4. Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodelling
5. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family
6. Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages
7. Molecular characterization of the gene for human cartilage gp-39 (CH13L1), a member of the chitinase protein family and a marker for late stages of macrophage differentiation
8. Chitotriosidase, a chitinase, and the 39 kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages
9. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis
10. The distribution of YKL-40 in osteoarthritic and normal human articular cartilage
11. Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization
12. Differential screening identifies genetic markers of monocyte to macrophage maturation
13. Strong induction of members of the chitinase family of proteins in atherosclerosis. Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages
14. YKL-40, a mamalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils
15. Chondrex: New marker of joint disease
16. Serum YKL-40 concentrations in patients with rheumatoid arthritis: Relation to disease activity
17. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint
18. Identification of proteins secreted by human osteoblastic cells in culture
19. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
20. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee
21. Magnetic resonance imaging-determined synovial membrane and joint effusion volumes in rheumatoid arthritis and osteoarthritis: Comparison with the macroscopic and microscopic appearance of the synovium
22. Immunohistochemistry in the study of normal and osteoarthritic articular cartilage
23. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen
24. Cartilage oligomeric matrix protein; isolation and characterization from human articular cartilage
25. Quantitation of proteoglycans as glycoaminoglycans in biological fluids using an Alcian blue dot analysis
26. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils
27. Human neutrophil gelatinase: A marker for circulating blood neutrophils. Purification and quantitation by enzyme linked immunosorbent assay
28. Characterization of two ELISAs for NGAL, a newly described lipocalin in human neutrophils
29. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma
30. COMP (cartilage oligometric matrix protein) is structurally related to the thrombospondins
31. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis
32. Relationship between serum cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis
33. Changes in bone and cartilage metabolism identified by serum markers in early osteoarthritis of the knee joint
34. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon
35. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids
36. Small fragment of cartilage oligomeric matrix protein (COMP) in synovial fluid and serum as markers for cartilage degradation
37. Neutrophils, host defense, and inflammation: A double-edged sword
38. The neutrophil in rheumatoid arthritis
39. Granulocyte survival in synovial exudate of patients with rheumatoid arthritis and other inflammatory joint disease
40. Degradation of human articular cartilage by neutrophils in synovial fluid
41. Granules of the human neutrophilic polymorphonuclear leukocyte
42. Tissue destruction by neutrophils
43. Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders
44. Circulating extracellular matrix components as markers for connective tissue response to inflammation. A clinical and experimental study with special emphasis on serum aminoterminal type III procollagen peptide in rheumatic diseases